Melqart Asset Management (UK) Ltd
13F filer · CIK 0001712901Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$1.05BU.S. long equity reported on 13F
Positions3914 new · 15 closed
Net flow last quarter-$272MBuys minus sells
Top 10 positions weight59.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 202639 positions | |||||
| $122M | 11.63% | 0.18% | +126.1% | Q4 2025 | |
| $77.8M | 7.40% | 1.24% | +30.4% | Q2 2021 | |
| $76.4M | 7.27% | 0.11% | +51.0% | Q4 2025 | |
| EAEAElectronic Arts Inc. | $73M | 6.95% | Not reported | -3.7% | Q1 2020 |
| $65.4M | 6.22% | 0.62% | -9.1% | Q1 2024 | |
| $58.6M | 5.58% | 0.47% | +127.0% | Q1 2026 | |
| CIGTLSChart Industries Inc | $44.8M | 4.27% | 0.45% | -19.1% | Q4 2025 |
| $40.9M | 3.90% | 0.39% | Not reported | Q3 2025 | |
| $38.7M | 3.68% | 0.20% | +24.1% | Q4 2025 | |
| $30.8M | 2.93% | 0.29% | +128.8% | Q1 2026 | |
| $27.3M | 2.60% | 0.00% | -32.8% | Q2 2022 | |
| $25.5M | 2.43% | 0.00% | -32.0% | Q1 2026 | |
| $24.9M | 2.37% | 0.00% | -49.4% | Q4 2021 | |
| $24M | 2.29% | 0.48% | -14.4% | Q3 2024 | |
| $22.7M | 2.16% | 0.06% | -55.1% | Q1 2026 | |
| $22.4M | 2.14% | 0.43% | +15.0% | Q1 2026 | |
| $20.5M | 1.95% | 0.00% | -63.2% | Q1 2025 | |
| $20.1M | 1.91% | 0.33% | Not reported | Q3 2020 | |
| $16.2M | 1.55% | 0.00% | Not reported | Q3 2020 | |
| ATAPGEApogee Therapeutics, Inc. | $15.6M | 1.48% | 0.16% | New | Q2 2026 |
| THTWOTwo Harbors Investment Corp. | $14.9M | 1.42% | Not reported | +218.7% | Q1 2026 |
| $13.7M | 1.31% | 0.01% | -80.7% | Q2 2021 | |
| $13.4M | 1.28% | 0.00% | New | Q2 2026 | |
| $13.4M | 1.27% | 0.00% | -88.1% | Q3 2025 | |
| $13.3M | 1.26% | 0.01% | Not reported | Q1 2023 | |
| $12.9M | 1.23% | 0.03% | -29.6% | Q3 2022 | |
| $12.8M | 1.21% | 0.65% | -15.4% | Q3 2025 | |
| $12M | 1.14% | 0.03% | New | Q2 2026 | |
| $11.8M | 1.13% | 0.16% | -62.5% | Q4 2025 | |
| $11.7M | 1.11% | 0.01% | Not reported | Q1 2025 | |
| $11.6M | 1.11% | 0.26% | +98.6% | Q1 2023 | |
| $8.41M | 0.80% | Not reported | +15.7% | Q4 2025 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $7.78M | 0.74% | 0.20% | New | Q2 2026 |
| $6.47M | 0.62% | 0.02% | Not reported | Q1 2022 | |
| $6.29M | 0.60% | 0.09% | New | Q2 2026 | |
| $6.06M | 0.58% | 0.01% | New | Q2 2026 | |
| $5.99M | 0.57% | 0.01% | New | Q2 2026 | |
| $3.75M | 0.36% | 17.34% | -9.9% | Q4 2025 | |
| $3.66M | 0.35% | Not reported | New | Q2 2026 | |
| Q1 2026Reported May 12, 202640 positions | |||||
| EAEAElectronic Arts Inc. | $75.4M | 7.43% | Not reported | +49.9% | Q1 2020 |
| $61.4M | 6.06% | 0.95% | +33.0% | Q2 2021 | |
| $55.7M | 5.49% | 0.08% | -20.9% | Q4 2025 | |
| $55.6M | 5.48% | 0.69% | +35.5% | Q1 2024 | |
| CIGTLSChart Industries Inc | $54.8M | 5.41% | 0.55% | +7.7% | Q4 2025 |
| CACWANClearwater Analytics Holdings, Inc. | $53.6M | 5.28% | Not reported | +194.5% | Q4 2025 |
| $46.2M | 4.55% | 0.07% | +7.8% | Q4 2025 | |
| $43.2M | 4.26% | 0.13% | Not reported | Q4 2025 | |
| $42.9M | 4.23% | 0.00% | +57.1% | Q4 2021 | |
| $39.4M | 3.88% | 0.00% | -0.2% | Q1 2025 | |
| $31.3M | 3.08% | 0.03% | -22.3% | Q3 2025 | |
| $28.9M | 2.85% | 0.16% | +1048.2% | Q4 2025 | |
| $26.9M | 2.65% | 0.21% | New | Q1 2026 | |
| TPTERNTerns Pharmaceuticals, Inc. | $26.7M | 2.64% | 0.44% | New | Q1 2026 |
| $26.3M | 2.59% | 0.14% | New | Q1 2026 | |
| $25.5M | 2.52% | 0.43% | +9.7% | Q4 2025 | |
| $24.9M | 2.46% | 0.00% | New | Q1 2026 | |
| $23.7M | 2.33% | 0.03% | -10.9% | Q2 2021 | |
| $23.1M | 2.27% | 0.12% | New | Q1 2026 | |
| $22.3M | 2.20% | 0.00% | -51.0% | Q4 2023 | |
| $20.9M | 2.06% | 0.55% | Not reported | Q3 2024 | |
| $20.1M | 1.99% | Not reported | New | Q1 2026 | |
| $18.6M | 1.83% | 0.37% | New | Q1 2026 | |
| $17.4M | 1.71% | 0.02% | -35.4% | Q1 2024 | |
| $14.7M | 1.45% | 2.78% | +3.3% | Q3 2025 | |
| $14.7M | 1.45% | 0.72% | +34.4% | Q3 2023 | |
| $14.2M | 1.40% | 0.00% | +2.1% | Q2 2022 | |
| $13.1M | 1.30% | 0.19% | New | Q1 2026 | |
| $13M | 1.28% | 0.13% | New | Q1 2026 | |
| $11.6M | 1.15% | 0.58% | +8.4% | Q1 2025 | |
| $10.2M | 1.01% | 0.00% | -17.4% | Q3 2023 | |
| $8.92M | 0.88% | 0.84% | +4967.1% | Q4 2025 | |
| $7.14M | 0.70% | Not reported | Not reported | Q4 2025 | |
| $6.9M | 0.68% | 0.83% | -4.2% | Q3 2025 | |
| $6.19M | 0.61% | 0.04% | -44.0% | Q3 2022 | |
| $5.29M | 0.52% | 0.13% | Not reported | Q1 2023 | |
| THTWOTwo Harbors Investment Corp. | $4.3M | 0.42% | Not reported | New | Q1 2026 |
| $2.98M | 0.29% | 0.08% | New | Q1 2026 | |
| $2.83M | 0.28% | 19.24% | +83.5% | Q4 2025 | |
| $1.52M | 0.15% | 0.04% | New | Q1 2026 | |
| Q4 2025Reported Feb 17, 202643 positions | |||||
| $73.9M | 7.28% | 0.10% | New | Q4 2025 | |
| FCFYBRFrontier Communications Parent, Inc. | $57.6M | 5.67% | Not reported | +143.9% | Q4 2024 |
| $50.9M | 5.01% | 0.00% | +91.5% | Q4 2023 | |
| CIGTLSChart Industries Inc | $50.8M | 5.00% | 0.55% | New | Q4 2025 |
| EAEAElectronic Arts Inc. | $50.4M | 4.96% | Not reported | Not reported | Q1 2020 |
| $46.5M | 4.58% | 0.73% | +35.1% | Q2 2021 | |
| $43.3M | 4.26% | 0.13% | New | Q4 2025 | |
| $43.1M | 4.24% | 0.07% | New | Q4 2025 | |
| $39.6M | 3.90% | 0.51% | -20.5% | Q1 2024 | |
| $38.3M | 3.77% | 0.14% | New | Q4 2025 | |
| $35.5M | 3.49% | 0.00% | +53.3% | Q1 2025 | |
| $31.7M | 3.12% | 0.04% | +176.5% | Q1 2021 | |
| PIPLYMPlymouth Industrial REIT, Inc. | $31.2M | 3.07% | 3.20% | New | Q4 2025 |
| $29.2M | 2.87% | 0.00% | +5.4% | Q4 2021 | |
| $27.2M | 2.67% | 0.39% | New | Q4 2025 | |
| ABRNAMAvidity Biosciences, Inc. | $25.7M | 2.53% | 0.24% | New | Q4 2025 |
| CCFLTConfluent, Inc. | $24.7M | 2.43% | 0.75% | +228.4% | Q4 2024 |
| $22.8M | 2.24% | 0.03% | -17.6% | Q2 2021 | |
| $21.2M | 2.09% | 2.71% | +122.3% | Q3 2025 | |
| CACWANClearwater Analytics Holdings, Inc. | $18.6M | 1.83% | Not reported | New | Q4 2025 |
| $17.1M | 1.69% | 0.03% | -47.0% | Q1 2024 | |
| $16.4M | 1.61% | 0.00% | Not reported | Q3 2023 | |
| $15.1M | 1.49% | 0.52% | +6.1% | Q3 2023 | |
| $15M | 1.48% | 0.04% | -57.4% | Q3 2025 | |
| $14.8M | 1.46% | 0.00% | +71.7% | Q3 2020 | |
| $14.7M | 1.44% | 0.00% | Not reported | Q2 2022 | |
| $11.6M | 1.15% | 0.03% | -14.6% | Q4 2021 | |
| $11.4M | 1.12% | 0.00% | +43.4% | Q3 2023 | |
| $10.5M | 1.04% | 0.54% | -5.4% | Q1 2025 | |
| $9.12M | 0.90% | 0.07% | -7.3% | Q3 2022 | |
| $7.41M | 0.73% | Not reported | New | Q4 2025 | |
| $7.27M | 0.72% | 0.89% | +45.1% | Q3 2025 | |
| $6.42M | 0.63% | Not reported | -59.0% | Q3 2024 | |
| CTCDTXCidara Therapeutics, Inc. | $5.84M | 0.58% | 0.08% | New | Q4 2025 |
| $5.75M | 0.57% | 0.03% | Not reported | Q3 2019 | |
| $5.21M | 0.51% | 0.01% | +134.3% | Q3 2020 | |
| $5.17M | 0.51% | 0.07% | Not reported | Q4 2023 | |
| $4.45M | 0.44% | 0.04% | -48.6% | Q3 2025 | |
| $2.89M | 0.28% | 0.02% | New | Q4 2025 | |
| $2.2M | 0.22% | 10.49% | New | Q4 2025 | |
| $2.18M | 0.21% | 0.04% | +421.1% | Q4 2021 | |
| KKWKennedy-Wilson Holdings, Inc. | $260K | 0.03% | 0.02% | New | Q4 2025 |
| $234K | 0.02% | 0.02% | New | Q4 2025 | |
| Q3 2025Reported Nov 14, 202542 positions | |||||
| AALEAllete Inc | $52.2M | 6.97% | 1.35% | -5.8% | Q4 2024 |
| $43.2M | 5.76% | 0.05% | New | Q3 2025 | |
| $43.1M | 5.75% | 0.66% | -40.9% | Q1 2024 | |
| $33.1M | 4.41% | 0.54% | Not reported | Q2 2021 | |
| WWNSWNS (Holdings) Limited | $29M | 3.87% | 0.89% | New | Q3 2025 |
| $28M | 3.74% | 0.00% | -6.7% | Q2 2019 | |
| $27.7M | 3.70% | 0.00% | -45.7% | Q4 2021 | |
| $27.4M | 3.65% | 0.04% | -18.6% | Q2 2021 | |
| $25.3M | 3.38% | 0.00% | -43.5% | Q4 2023 | |
| FCFYBRFrontier Communications Parent, Inc. | $23.2M | 3.09% | Not reported | Not reported | Q4 2024 |
| $22.5M | 3.01% | 0.05% | -30.1% | Q1 2024 | |
| $21.3M | 2.84% | 0.00% | -12.4% | Q1 2025 | |
| $17.7M | 2.36% | 0.02% | New | Q3 2025 | |
| $17.1M | 2.28% | 0.05% | Not reported | Q4 2020 | |
| $16.8M | 2.25% | Not reported | +111.8% | Q3 2024 | |
| $16.7M | 2.23% | 0.10% | New | Q3 2025 | |
| $15.5M | 2.07% | 0.55% | New | Q3 2025 | |
| $14.9M | 1.98% | 0.49% | +268.2% | Q3 2024 | |
| $14.5M | 1.94% | 0.52% | +0.5% | Q1 2025 | |
| $14.4M | 1.92% | 0.00% | New | Q3 2025 | |
| $13.2M | 1.76% | Not reported | Not reported | Q1 2021 | |
| $11.8M | 1.57% | 0.02% | +160.2% | Q1 2021 | |
| $11.6M | 1.55% | 0.49% | Not reported | Q3 2023 | |
| VPVRNAVerona Pharma plc | $11.5M | 1.54% | 0.02% | New | Q3 2025 |
| $10.1M | 1.35% | 0.04% | Not reported | Q4 2021 | |
| $10.1M | 1.34% | 0.08% | +83.2% | Q3 2022 | |
| $9.8M | 1.31% | 1.23% | New | Q3 2025 | |
| $8.64M | 1.15% | 0.04% | +144.8% | Q2 2021 | |
| $8.49M | 1.13% | 0.22% | -7.6% | Q3 2020 | |
| $8.37M | 1.12% | 0.00% | -29.3% | Q3 2020 | |
| $8.23M | 1.10% | 0.00% | Not reported | Q3 2020 | |
| $6.99M | 0.93% | 0.02% | New | Q3 2025 | |
| $6.71M | 0.90% | 0.00% | Not reported | Q1 2023 | |
| $5.47M | 0.73% | 0.63% | New | Q3 2025 | |
| $5.45M | 0.73% | 0.10% | New | Q3 2025 | |
| CCFLTConfluent, Inc. | $4.92M | 0.66% | 0.23% | Not reported | Q4 2024 |
| $4.73M | 0.63% | 0.05% | +17.0% | Q2 2024 | |
| $4.67M | 0.62% | 0.00% | Not reported | Q3 2023 | |
| $4.36M | 0.58% | 0.03% | +16.4% | Q1 2024 | |
| $4.16M | 0.56% | 0.05% | Not reported | Q1 2021 | |
| $2.05M | 0.27% | 0.00% | -76.9% | Q3 2020 | |
| $437K | 0.06% | 0.01% | Not reported | Q4 2021 | |
Premium opens every quarter this fund has filed